Biomedical Research Sector In Australia All Set To Expand
Monash University- Australia has gone on to buy a prominent Parkville property that will go on to become a major addition to its campus,...
Japan, Norway Partner To Strengthen Global Pandemic Response
The Coalition For Epidemic Preparedness Innovation in Norway and the Strategic Centre of Biomedical Advanced Vaccine Research and Development for Preparedness and Response have...
China Continues To Attract Multinational Pharma Investment
A collection of notable recent developments in the Chinese pharmaceutical industry indicates that despite ongoing political tensions, multinational pharmaceutical companies still find China an...
CRO Market Outlook: Growth Potential & Regulatory Obstacles
As per insights, the global clinical research organization (CRO) market is projected to achieve a value of $139.56 billion by 2033. The market is...
US – China Trade In Pharmaceuticals Soars In Recent Years
The US-China trade in pharmaceuticals has shifted due to the trade war and the pandemic. While some sectors have seen a decline, pharmaceutical trade...
Biotech M&A Is Set For Rebound With Billion-Dollar Deals
2022 was an unremarkable year for biotech mergers and acquisitions (M&A) as the industry experienced a decline in both the number and value of...
Centogene, Lifera Join Forces To Improve Multiomic Testing
Centogene, a life science company based in Germany that specializes in rare and neurodegenerative diseases, and Lifera, a biopharmaceutical company owned by the Public...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...